Scott Hammond

Person

Olney, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number RE49908
- Issue date Apr 9, 2024
- MedImmune, LLC
- Srinath Kasturirangan
Information Patent Grant
Bispecific PD-1 and TIGIT binding proteins and uses thereof
- Patent number 11,939,382
- Issue date Mar 26, 2024
- MedImmune, LLC
- Yariv Mazor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 11,525,012
- Issue date Dec 13, 2022
- MedImmune Limited
- Carl Hay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 11,518,809
- Issue date Dec 6, 2022
- MedImmune Limited
- Christophe Queva
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 11,279,759
- Issue date Mar 22, 2022
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 10,556,968
- Issue date Feb 11, 2020
- MedImmune Limited
- Carl Hay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific binding proteins and uses thereof
- Patent number 10,457,732
- Issue date Oct 29, 2019
- MedImmune, LLC
- Srinath Kasturirangan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 10,400,039
- Issue date Sep 3, 2019
- MedImmune Limited
- Christophe Queva
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 10,287,362
- Issue date May 14, 2019
- MedImmune Limited
- Carl Hay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating cancer with humanized anti-OX40 antibodies
- Patent number 10,150,815
- Issue date Dec 11, 2018
- MedImmune, LLC
- Scott A. Hammond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding molecules specific for CD73 and uses thereof
- Patent number 9,938,356
- Issue date Apr 10, 2018
- MedImmune Limited
- Carl Hay
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-OX40 antibodies and uses thereof
- Patent number 9,738,723
- Issue date Aug 22, 2017
- MedImmune, LLC
- Scott A. Hammond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
OX40L fusion proteins and uses thereof
- Patent number 9,718,870
- Issue date Aug 1, 2017
- MedImmune, LLC
- Melissa Damschroder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 9,493,565
- Issue date Nov 15, 2016
- MedImmune Limited
- Christophe Queva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein formulation
- Patent number 9,308,257
- Issue date Apr 12, 2016
- MedImmune, LLC
- Monika S. Sharma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted binding agents against B7-H1
- Patent number 8,779,108
- Issue date Jul 15, 2014
- MedImmune, Limited
- Christophe Queva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF
- Publication number 20240287183
- Publication date Aug 29, 2024
- Medimmune, LLC
- Yariv MAZOR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20240075160
- Publication date Mar 7, 2024
- Medimmune, LLC
- Bilal OMAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20230340152
- Publication date Oct 26, 2023
- MEDIMMUNE LIMITED
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20230235062
- Publication date Jul 27, 2023
- MEDIMMUNE LIMITED
- CHRISTOPHE QUEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEROF
- Publication number 20220411509
- Publication date Dec 29, 2022
- Medimmune, LLC
- Yariv MAZOR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODY TARGETING PD-1 AND TIM-3
- Publication number 20220332818
- Publication date Oct 20, 2022
- Medimmune, LLC
- Kristen POLLIZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20220251204
- Publication date Aug 11, 2022
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20210017282
- Publication date Jan 21, 2021
- MEDIMMUNE LIMITED
- CHRISTOPHE QUEVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20200172622
- Publication date Jun 4, 2020
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20200079877
- Publication date Mar 12, 2020
- MEDIMMUNE LIMITED
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20190292274
- Publication date Sep 26, 2019
- MedImmune Limited
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20190241659
- Publication date Aug 8, 2019
- Medimmune, LLC
- JOHN MUMM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-OX40 Antibodies and Uses Thereof
- Publication number 20190169303
- Publication date Jun 6, 2019
- Medimmune, LLC
- SCOTT A. HAMMOND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20180194858
- Publication date Jul 12, 2018
- MEDIMMUNE LIMITED
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
- Publication number 20180072808
- Publication date Mar 15, 2018
- Medimmune, LLC
- SCOTT A. HAMMOND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20180022807
- Publication date Jan 25, 2018
- Medimmune, LLC
- Srinath KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20170137522
- Publication date May 18, 2017
- MEDIMMUNE LIMITED
- CHRISTOPHE QUEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions And Methods For Modulating And Redirecting Immune Resp...
- Publication number 20170015758
- Publication date Jan 19, 2017
- Medimmune, LLC
- Scott A. HAMMOND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA
- Publication number 20160347848
- Publication date Dec 1, 2016
- MEDIMMUNE LIMITED
- Scott A. HAMMOND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN FORMULATION
- Publication number 20160215051
- Publication date Jul 28, 2016
- Medimmune, LLC
- Monika S. SHARMA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF
- Publication number 20160194407
- Publication date Jul 7, 2016
- Carl HAY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF
- Publication number 20160137740
- Publication date May 19, 2016
- Medimmune, LLC
- SCOTT A. HAMMOND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OX40L FUSION PROTEINS AND USES THEREOF
- Publication number 20160024176
- Publication date Jan 28, 2016
- Medimmune, LLC
- Melissa Damschroder
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TARGETED BINDING AGENTS AGAINST B7-H1
- Publication number 20140356353
- Publication date Dec 4, 2014
- CHRISTOPHE QUEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMENS FOR TREATMENT OF CEA-EXPRESSING CANCERS
- Publication number 20140242081
- Publication date Aug 28, 2014
- MICROMET AG
- Scott Hammond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR DETECTING AND TREATING CEA-EXPRESSING...
- Publication number 20130035249
- Publication date Feb 7, 2013
- Medimmune, LLC
- Scott Hammond
- G01 - MEASURING TESTING
Information Patent Application
Targeted Binding Agents Against B7-H1
- Publication number 20130034559
- Publication date Feb 7, 2013
- Medlmmune Limited
- Christophe Queva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Protein Formulation
- Publication number 20100303827
- Publication date Dec 2, 2010
- One Medimmune Way
- Monika S. Sharma, SR.
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Transcutaneous immunostimulation
- Publication number 20090136480
- Publication date May 28, 2009
- Iomai Corporation
- Gregory M. Glenn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EphA2 BiTE molecules and uses thereof
- Publication number 20080044413
- Publication date Feb 21, 2008
- Scott A. Hammond
- C07 - ORGANIC CHEMISTRY

Scott Hammond

Person

Patents Grantslast 30 patents

Bispecific binding proteins and uses thereof

Bispecific PD-1 and TIGIT binding proteins and uses thereof

Binding molecules specific for CD73 and uses thereof

Targeted binding agents against B7-H1

Bispecific binding proteins and uses thereof

Binding molecules specific for CD73 and uses thereof

Bispecific binding proteins and uses thereof

Targeted binding agents against B7-H1

Binding molecules specific for CD73 and uses thereof

Method of treating cancer with humanized anti-OX40 antibodies

Binding molecules specific for CD73 and uses thereof

Humanized anti-OX40 antibodies and uses thereof

OX40L fusion proteins and uses thereof

Targeted binding agents against B7-H1

Protein formulation

Targeted binding agents against B7-H1

Patents Applicationslast 30 patents

BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEREOF

COMBINATION THERAPIES FOR TREATMENT OF CANCER

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

TARGETED BINDING AGENTS AGAINST B7-H1

BISPECIFIC PD-1 AND TIGIT BINDING PROTEINS AND USES THEROF

BISPECIFIC ANTIBODY TARGETING PD-1 AND TIM-3

BISPECIFIC BINDING PROTEINS AND USES THEREOF

TARGETED BINDING AGENTS AGAINST B7-H1

BISPECIFIC BINDING PROTEINS AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

BISPECIFIC FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

Humanized Anti-OX40 Antibodies and Uses Thereof

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

TARGETED BINDING AGENTS AGAINST B7-H1

Compositions And Methods For Modulating And Redirecting Immune Resp...

THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA

PROTEIN FORMULATION

BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF

HUMANIZED ANTI-OX40 ANTIBODIES AND USES THEREOF

OX40L FUSION PROTEINS AND USES THEREOF

TARGETED BINDING AGENTS AGAINST B7-H1

DOSING REGIMENS FOR TREATMENT OF CEA-EXPRESSING CANCERS

METHODS AND COMPOSITIONS FOR DETECTING AND TREATING CEA-EXPRESSING...

Targeted Binding Agents Against B7-H1

Protein Formulation

Transcutaneous immunostimulation

EphA2 BiTE molecules and uses thereof